Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 405 | Longs Won 155/405 38% | Profit Factor 0.89 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $19,866.94 |
| Average Win $3,099.28 | Best Trade (Jan 14) $288,811.68 | Sharpe Ratio -19.34 |
| Average Loss -$2,168.27 | Worst Trade (May 15) -$257,588.31 | Z-Score -3.99 (100%) |
| Commissions $0 | Avg. Trade Length 2m 2d | Expectancy -$149.05 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 105.1% | 103.54% | 102.63% | 102% | 101.51% | 101.11% | 100.77% | 100.48% | 100.23% |
| Consecutive Losing Trades | 18 | 16 | 15 | 13 | 11 | 9 | 7 | 5 | 4 | 2 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
PLSE Pulse Biosciences, Inc. | 859.47 | $44,674.99 | $39,634.23 | - | -$5,040.76 | -11.28% | -0.443% |